Abstract
Endogenous chemical mediators play seminal roles in the initiation, persistence, and resolution of inflammation. Recent studies have revealed parallels between inflammatory mediators and mechanisms common to oral and systemic diseases. These relationships imply that novel therapeutics that profoundly modulate inflammatory mediators may improve clinical outcomes. Key source for this article is a 2008 conference reported in a Journal of Periodontology supplement titled Proceedings of the 2008 Workshop on Inflammation; Inflammation and Periodontal Diseases: A Reappraisal.
MeSH terms
-
Adaptive Immunity / genetics
-
Adaptive Immunity / physiology*
-
Alzheimer Disease / immunology
-
C-Reactive Protein / immunology
-
Cardiovascular Diseases / genetics
-
Cardiovascular Diseases / immunology
-
Chronic Periodontitis / immunology*
-
Cytokines / immunology
-
Diabetes Mellitus, Type 2 / genetics
-
Diabetes Mellitus, Type 2 / immunology
-
Environmental Exposure
-
Epigenesis, Genetic
-
Genes / genetics
-
Genetic Predisposition to Disease / genetics*
-
Humans
-
Immunity, Innate / genetics
-
Immunity, Innate / physiology*
-
Inflammation / genetics
-
Inflammation / immunology*
-
Inflammation Mediators / physiology
-
Metabolic Syndrome / genetics
-
Metabolic Syndrome / immunology
Substances
-
Cytokines
-
Inflammation Mediators
-
C-Reactive Protein